kaiser glp-1 Weight Management Programs and Requirements for PSHB Does Kaiser cover Zepbound?

Description

Phase I clinical trial results for Amgens experimental weight-loss drug, MariTide, indicate it may provide longer-lasting effects compared to existing glucagon-like peptide-1 (GLP-1) treatments such as Novo Nordisks Wegovy and EliLillys Zepbound.

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes

Compounding pharmacies and investors have brought legal challenges to enjoin the FDA from enforcing the changes to the shortage list, but have so far been unsuccessful

FDA approves Foundayo (orforglipron) the first GLP-1 pill with no food restrictions

Supresa Saffron Extract: Standardized to 0.3% safranal, this extract has been associated with a 69% decrease in hunger and a 55% reduction in snacking events over an eight-week period